English

IDEXX LABORATORIES INC /DE

EDGAR

IDXX Quarterly report (10-Q) · filed 2026-08-04

Annual consolidated revenue for 2025: about USD 4.304B, using the latest reported figures. The previous period, 2024, was about USD 3.898B.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.22 billion USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 1216585000 USD Source

Operating margin

34.98%

2026 Q2 · %

Exact inputs and evidence

Operating Income: 425566000 USD Source
Revenue: 1216585000 USD Source

Operating cash flow

347 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 613410000 USD Source
Operating Cash Flow: 266248000 USD Source

Free cash flow

323 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 613410000 USD Source
Operating Cash Flow: 266248000 USD Source
Capital Expenditure: 56630000 USD Source
Capital Expenditure: 31984000 USD Source

Cash and cash equivalents: 197 million USD 2026-06-30 Source
Exact value

196933000 USD
Long-term debt including current maturities: 450 million USD 2025-12-31 Source
Exact value

450000000 USD
Shares outstanding: 78.9 million shares 2026-06-30 Source
Exact value

78874000 shares

Reported share-count change

-1.59% · -1.28 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

80150000 shares · 2025-06-30· Source
78874000 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-04.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2025-12-31
Operating income: 10 of 11 periods available· newest 2025-12-31
Net income: 10 of 11 periods available· newest 2025-12-31
Operating cash flow: 10 of 11 periods available· newest 2025-12-31
Capital expenditure: 10 of 11 periods available· newest 2025-12-31
Total assets: 9 of 11 periods available· newest 2025-12-31
Total liabilities: 9 of 11 periods available· newest 2025-12-31
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 9 of 11 periods available· newest 2025-12-31
Shares outstanding: 9 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+10.4%

Prior period

USD 3.9 billion

2024-01-01 – 2024-12-31
Current period

USD 4.3 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

4303702000 − 3897504000 = 406198000 USD

3897504000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
4303702000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · IDEXX LABORATORIES INC /DE · 2025-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Year-over-year change in Revenue: 406198000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4303702000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#2318931 Filing: 000087471626000038 Input fundies:Revenue: 3897504000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#2355646 Filing: 000087471626000038
The citation records this snapshot. The page link may show a newer release later.
Net income
+19.3%

Prior period

USD 887.87 million

2024-01-01 – 2024-12-31
Current period

USD 1.06 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

1059464000 − 887867000 = 171597000 USD

887867000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1059464000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · IDEXX LABORATORIES INC /DE · 2025-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Year-over-year change in Net income: 171597000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 1059464000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1462541 Filing: 000087471626000038 Input fundies:NetIncome: 887867000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1463310 Filing: 000087471626000038
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+27.2%

Prior period

USD 929 million

2024-01-01 – 2024-12-31
Current period

USD 1.18 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

1181805000 − 929001000 = 252804000 USD

929001000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1181805000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · IDEXX LABORATORIES INC /DE · 2025-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Year-over-year change in Operating cash flow: 252804000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 1181805000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1486598 Filing: 000087471626000038 Input fundies:OperatingCashFlow: 929001000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1487253 Filing: 000087471626000038
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+3.1%

Prior period

USD 120.92 million

2024-01-01 – 2024-12-31
Current period

USD 124.68 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

124676000 − 120922000 = 3754000 USD

120922000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
124676000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · IDEXX LABORATORIES INC /DE · 2025-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Year-over-year change in Capital expenditure: 3754000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 124676000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1489549 Filing: 000087471626000038 Input fundies:CapitalExpenditure: 120922000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1490140 Filing: 000087471626000038
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 4.3 billion 100% of revenue
Cost of revenue USD 1.64 billion 38% of revenue
Operating expenses USD 1.3 billion 30% of revenue
Operating income USD 1.36 billion 32% of revenue
Tax, interest and other Derived USD 300.57 million 7% of revenue
Net income USD 1.06 billion 25% of revenue

Cash

Operating cash flow USD 1.18 billion 27% of revenue
Capital expenditure USD 124.68 million 2.9% of revenue
Free cash flow Derived USD 1.06 billion 25% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 13%80%
2017 13%79%
2018 17%78%
2019 18%77%
2020 21%74%
2021 23%71%
2022 20%73%
2023 23%70%
2024 23%71%
2025 25%68%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	1775423000	1425184000 Derived	350239000	128194000 Derived	222045000	274156000 Derived	Source 2016-01-01 – 2016-12-31: 1775423000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 350239000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 222045000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 338943000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 64787000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	1969058000	1556030000 Derived	413028000	149884000 Derived	263144000	298892000 Derived	Source 2017-01-01 – 2017-12-31: 1969058000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: 413028000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 263144000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 373276000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 74384000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	2213242000	1721907000 Derived	491335000	114304000 Derived	377031000	284333000 Derived	Source 2018-01-01 – 2018-12-31: 2213242000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 491335000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 377031000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 400084000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 115751000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	2406908000	1854062000 Derived	552846000	125126000 Derived	427720000	304189000 Derived	Source 2019-01-01 – 2019-12-31: 2406908000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 552846000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: 427720000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 459158000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 154969000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	2706655000	2012131000 Derived	694524000	112748000 Derived	581776000	541105000 Derived	Source 2020-01-01 – 2020-12-31: 2706655000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 694524000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 581776000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 648063000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 106958000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	3215360000	2283332000 Derived	932028000	187183000 Derived	744845000	635997000 Derived	Source 2021-01-01 – 2021-12-31: 3215360000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 932028000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 744845000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 755546000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 119549000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	3367324000	2468559000 Derived	898765000	219676000 Derived	679089000	394146000 Derived	Source 2022-01-01 – 2022-12-31: 3367324000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 898765000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 679089000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 542984000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 148838000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	3660953000	2563825000 Derived	1097128000	252086000 Derived	845042000	772879000 Derived	Source 2023-01-01 – 2023-12-31: 3660953000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: 1097128000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: 845042000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 906510000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 133631000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	3897504000	2769167000 Derived	1128337000	240470000 Derived	887867000	808079000 Derived	Source 2024-01-01 – 2024-12-31: 3897504000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: 1128337000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 887867000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 929001000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 120922000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	4303702000	2943671000 Derived	1360031000	300567000 Derived	1059464000	1057129000 Derived	Source 2025-01-01 – 2025-12-31: 4303702000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: 1360031000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: 1059464000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 1181805000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 124676000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4.3B 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	1775423000	Revenue: 1775423000 Open source
20172017-12-31	Revenue	1969058000	Revenue: 1969058000 Open source
20182018-12-31	Revenue	2213242000	Revenue: 2213242000 Open source
20192019-12-31	Revenue	2406908000	Revenue: 2406908000 Open source
20202020-12-31	Revenue	2706655000	Revenue: 2706655000 Open source
20212021-12-31	Revenue	3215360000	Revenue: 3215360000 Open source
20222022-12-31	Revenue	3367324000	Revenue: 3367324000 Open source
20232023-12-31	Revenue	3660953000	Revenue: 3660953000 Open source
20242024-12-31	Revenue	3897504000	Revenue: 3897504000 Open source
20252025-12-31	Revenue	4303702000	Revenue: 4303702000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

10.4% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	No prior comparable period	Revenue: 1775423000 Open source
20172017-12-31	Year over year	10.9%	Revenue: 1969058000 Open source Revenue: 1775423000 Open source
20182018-12-31	Year over year	12.4%	Revenue: 2213242000 Open source Revenue: 1969058000 Open source
20192019-12-31	Year over year	8.8%	Revenue: 2406908000 Open source Revenue: 2213242000 Open source
20202020-12-31	Year over year	12.5%	Revenue: 2706655000 Open source Revenue: 2406908000 Open source
20212021-12-31	Year over year	18.8%	Revenue: 3215360000 Open source Revenue: 2706655000 Open source
20222022-12-31	Year over year	4.7%	Revenue: 3367324000 Open source Revenue: 3215360000 Open source
20232023-12-31	Year over year	8.7%	Revenue: 3660953000 Open source Revenue: 3367324000 Open source
20242024-12-31	Year over year	6.5%	Revenue: 3897504000 Open source Revenue: 3660953000 Open source
20252025-12-31	Year over year	10.4%	Revenue: 4303702000 Open source Revenue: 3897504000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 31.6% 2025

Net margin 24.6% 2025

Free cash flow margin 24.6% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	19.7%	Operating Income: 350239000 Open source Revenue: 1775423000 Open source
20172017-12-31	Operating margin	21%	Operating Income: 413028000 Open source Revenue: 1969058000 Open source
20182018-12-31	Operating margin	22.2%	Operating Income: 491335000 Open source Revenue: 2213242000 Open source
20192019-12-31	Operating margin	23%	Operating Income: 552846000 Open source Revenue: 2406908000 Open source
20202020-12-31	Operating margin	25.7%	Operating Income: 694524000 Open source Revenue: 2706655000 Open source
20212021-12-31	Operating margin	29%	Operating Income: 932028000 Open source Revenue: 3215360000 Open source
20222022-12-31	Operating margin	26.7%	Operating Income: 898765000 Open source Revenue: 3367324000 Open source
20232023-12-31	Operating margin	30%	Operating Income: 1097128000 Open source Revenue: 3660953000 Open source
20242024-12-31	Operating margin	29%	Operating Income: 1128337000 Open source Revenue: 3897504000 Open source
20252025-12-31	Operating margin	31.6%	Operating Income: 1360031000 Open source Revenue: 4303702000 Open source
20162016-12-31	Net margin	12.5%	Net Income: 222045000 Open source Revenue: 1775423000 Open source
20172017-12-31	Net margin	13.4%	Net Income: 263144000 Open source Revenue: 1969058000 Open source
20182018-12-31	Net margin	17%	Net Income: 377031000 Open source Revenue: 2213242000 Open source
20192019-12-31	Net margin	17.8%	Net Income: 427720000 Open source Revenue: 2406908000 Open source
20202020-12-31	Net margin	21.5%	Net Income: 581776000 Open source Revenue: 2706655000 Open source
20212021-12-31	Net margin	23.2%	Net Income: 744845000 Open source Revenue: 3215360000 Open source
20222022-12-31	Net margin	20.2%	Net Income: 679089000 Open source Revenue: 3367324000 Open source
20232023-12-31	Net margin	23.1%	Net Income: 845042000 Open source Revenue: 3660953000 Open source
20242024-12-31	Net margin	22.8%	Net Income: 887867000 Open source Revenue: 3897504000 Open source
20252025-12-31	Net margin	24.6%	Net Income: 1059464000 Open source Revenue: 4303702000 Open source
20162016-12-31	Free cash flow margin	15.4%	Revenue: 1775423000 Open source Operating Cash Flow: 338943000 Open source Capital Expenditure: 64787000 Open source
20172017-12-31	Free cash flow margin	15.2%	Revenue: 1969058000 Open source Operating Cash Flow: 373276000 Open source Capital Expenditure: 74384000 Open source
20182018-12-31	Free cash flow margin	12.8%	Revenue: 2213242000 Open source Operating Cash Flow: 400084000 Open source Capital Expenditure: 115751000 Open source
20192019-12-31	Free cash flow margin	12.6%	Revenue: 2406908000 Open source Operating Cash Flow: 459158000 Open source Capital Expenditure: 154969000 Open source
20202020-12-31	Free cash flow margin	20%	Revenue: 2706655000 Open source Operating Cash Flow: 648063000 Open source Capital Expenditure: 106958000 Open source
20212021-12-31	Free cash flow margin	19.8%	Revenue: 3215360000 Open source Operating Cash Flow: 755546000 Open source Capital Expenditure: 119549000 Open source
20222022-12-31	Free cash flow margin	11.7%	Revenue: 3367324000 Open source Operating Cash Flow: 542984000 Open source Capital Expenditure: 148838000 Open source
20232023-12-31	Free cash flow margin	21.1%	Revenue: 3660953000 Open source Operating Cash Flow: 906510000 Open source Capital Expenditure: 133631000 Open source
20242024-12-31	Free cash flow margin	20.7%	Revenue: 3897504000 Open source Operating Cash Flow: 929001000 Open source Capital Expenditure: 120922000 Open source
20252025-12-31	Free cash flow margin	24.6%	Revenue: 4303702000 Open source Operating Cash Flow: 1181805000 Open source Capital Expenditure: 124676000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 1.2B 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	338943000	Operating Cash Flow: 338943000 Open source
20172017-12-31	Operating cash flow	373276000	Operating Cash Flow: 373276000 Open source
20182018-12-31	Operating cash flow	400084000	Operating Cash Flow: 400084000 Open source
20192019-12-31	Operating cash flow	459158000	Operating Cash Flow: 459158000 Open source
20202020-12-31	Operating cash flow	648063000	Operating Cash Flow: 648063000 Open source
20212021-12-31	Operating cash flow	755546000	Operating Cash Flow: 755546000 Open source
20222022-12-31	Operating cash flow	542984000	Operating Cash Flow: 542984000 Open source
20232023-12-31	Operating cash flow	906510000	Operating Cash Flow: 906510000 Open source
20242024-12-31	Operating cash flow	929001000	Operating Cash Flow: 929001000 Open source
20252025-12-31	Operating cash flow	1181805000	Operating Cash Flow: 1181805000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 1.1B 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	274156000	Operating Cash Flow: 338943000 Open source Capital Expenditure: 64787000 Open source
20172017-12-31	Free cash flow	298892000	Operating Cash Flow: 373276000 Open source Capital Expenditure: 74384000 Open source
20182018-12-31	Free cash flow	284333000	Operating Cash Flow: 400084000 Open source Capital Expenditure: 115751000 Open source
20192019-12-31	Free cash flow	304189000	Operating Cash Flow: 459158000 Open source Capital Expenditure: 154969000 Open source
20202020-12-31	Free cash flow	541105000	Operating Cash Flow: 648063000 Open source Capital Expenditure: 106958000 Open source
20212021-12-31	Free cash flow	635997000	Operating Cash Flow: 755546000 Open source Capital Expenditure: 119549000 Open source
20222022-12-31	Free cash flow	394146000	Operating Cash Flow: 542984000 Open source Capital Expenditure: 148838000 Open source
20232023-12-31	Free cash flow	772879000	Operating Cash Flow: 906510000 Open source Capital Expenditure: 133631000 Open source
20242024-12-31	Free cash flow	808079000	Operating Cash Flow: 929001000 Open source Capital Expenditure: 120922000 Open source
20252025-12-31	Free cash flow	1057129000	Operating Cash Flow: 1181805000 Open source Capital Expenditure: 124676000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

52.1% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2016-12-31	Liabilities / assets	Not reported	No source recorded
20172017-12-31	Liabilities / assets	103.1%	Total Liabilities: 1767258000 Open source Total Assets: 1713416000 Open source
20182018-12-31	Liabilities / assets	100.6%	Total Liabilities: 1546582000 Open source Total Assets: 1537349000 Open source
20192019-12-31	Liabilities / assets	90.3%	Total Liabilities: 1654650000 Open source Total Assets: 1832475000 Open source
20202020-12-31	Liabilities / assets	72.4%	Total Liabilities: 1661766000 Open source Total Assets: 2294561000 Open source
20212021-12-31	Liabilities / assets	71.7%	Total Liabilities: 1747211000 Open source Total Assets: 2437203000 Open source
20222022-12-31	Liabilities / assets	77.8%	Total Liabilities: 2138028000 Open source Total Assets: 2746765000 Open source
20232023-12-31	Liabilities / assets	54.5%	Total Liabilities: 1775395000 Open source Total Assets: 3259925000 Open source
20242024-12-31	Liabilities / assets	51.6%	Total Liabilities: 1698130000 Open source Total Assets: 3293443000 Open source
20252025-12-31	Liabilities / assets	52.1%	Total Liabilities: 1745376000 Open source Total Assets: 3350759000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.23× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2016-12-31	Current assets / current liabilities	Not reported	No source recorded
20172017-12-31	Current assets / current liabilities	0.97×	Current Assets: 971985000 Open source Current Liabilities: 1004567000 Open source
20182018-12-31	Current assets / current liabilities	0.85×	Current Assets: 654172000 Open source Current Liabilities: 770444000 Open source
20192019-12-31	Current assets / current liabilities	0.94×	Current Assets: 679639000 Open source Current Liabilities: 725337000 Open source
20202020-12-31	Current assets / current liabilities	1.82×	Current Assets: 1062738000 Open source Current Liabilities: 582761000 Open source
20212021-12-31	Current assets / current liabilities	1.25×	Current Assets: 955655000 Open source Current Liabilities: 763579000 Open source
20222022-12-31	Current assets / current liabilities	0.89×	Current Assets: 1101477000 Open source Current Liabilities: 1235803000 Open source
20232023-12-31	Current assets / current liabilities	1.57×	Current Assets: 1495254000 Open source Current Liabilities: 951547000 Open source
20242024-12-31	Current assets / current liabilities	1.31×	Current Assets: 1399897000 Open source Current Liabilities: 1067916000 Open source
20252025-12-31	Current assets / current liabilities	1.23×	Current Assets: 1413827000 Open source Current Liabilities: 1148814000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	USD 222.05 million Exact value Exact value: 222045000 USD 2016-01-01 – 2016-12-31: 222045000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDEXX LABORATORIES INC /DE · 2016-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Net Income: 222045000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 222045000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471619000004/idxx-20181231.xml#551991 Filing: 000087471619000004 The citation records this snapshot. The page link may show a newer release later.	USD 338.94 million Exact value Exact value: 338943000 USD 2016-01-01 – 2016-12-31: 338943000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEXX LABORATORIES INC /DE · 2016-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Operating Cash Flow: 338943000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 338943000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471619000004/idxx-20181231.xml#548768 Filing: 000087471619000004 The citation records this snapshot. The page link may show a newer release later.	USD 64.79 million Exact value Exact value: 64787000 USD 2016-01-01 – 2016-12-31: 64787000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEXX LABORATORIES INC /DE · 2016-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Capital Expenditure: 64787000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 64787000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471619000004/idxx-20181231.xml#595168 Filing: 000087471619000004 The citation records this snapshot. The page link may show a newer release later.	USD 274.16 million Calculation and evidence 338943000 − 64787000 USD Exact free cash flow: 274156000 USD 2016-01-01 – 2016-12-31: 338943000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 64787000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEXX LABORATORIES INC /DE · 2016-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Free cash flow: 274156000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 338943000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471619000004/idxx-20181231.xml#548768 Filing: 000087471619000004 Input fundies:CapitalExpenditure: 64787000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471619000004/idxx-20181231.xml#595168 Filing: 000087471619000004 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	USD 263.14 million Exact value Exact value: 263144000 USD 2017-01-01 – 2017-12-31: 263144000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDEXX LABORATORIES INC /DE · 2017-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Net Income: 263144000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: 263144000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471620000006/idxx201910k.htm#3579698 Filing: 000087471620000006 The citation records this snapshot. The page link may show a newer release later.	USD 373.28 million Exact value Exact value: 373276000 USD 2017-01-01 – 2017-12-31: 373276000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEXX LABORATORIES INC /DE · 2017-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Operating Cash Flow: 373276000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 373276000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471620000006/idxx201910k.htm#2221418 Filing: 000087471620000006 The citation records this snapshot. The page link may show a newer release later.	USD 74.38 million Exact value Exact value: 74384000 USD 2017-01-01 – 2017-12-31: 74384000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEXX LABORATORIES INC /DE · 2017-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Capital Expenditure: 74384000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 74384000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471620000006/idxx201910k.htm#2226172 Filing: 000087471620000006 The citation records this snapshot. The page link may show a newer release later.	USD 298.89 million Calculation and evidence 373276000 − 74384000 USD Exact free cash flow: 298892000 USD 2017-01-01 – 2017-12-31: 373276000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 74384000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEXX LABORATORIES INC /DE · 2017-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Free cash flow: 298892000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 373276000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471620000006/idxx201910k.htm#2221418 Filing: 000087471620000006 Input fundies:CapitalExpenditure: 74384000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471620000006/idxx201910k.htm#2226172 Filing: 000087471620000006 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 377.03 million Exact value Exact value: 377031000 USD 2018-01-01 – 2018-12-31: 377031000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDEXX LABORATORIES INC /DE · 2018-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Net Income: 377031000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 377031000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471621000008/idxx-20201231.htm#3240869 Filing: 000087471621000008 The citation records this snapshot. The page link may show a newer release later.	USD 400.08 million Exact value Exact value: 400084000 USD 2018-01-01 – 2018-12-31: 400084000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEXX LABORATORIES INC /DE · 2018-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Operating Cash Flow: 400084000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 400084000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471621000008/idxx-20201231.htm#1807960 Filing: 000087471621000008 The citation records this snapshot. The page link may show a newer release later.	USD 115.75 million Exact value Exact value: 115751000 USD 2018-01-01 – 2018-12-31: 115751000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEXX LABORATORIES INC /DE · 2018-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Capital Expenditure: 115751000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 115751000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471621000008/idxx-20201231.htm#1811915 Filing: 000087471621000008 The citation records this snapshot. The page link may show a newer release later.	USD 284.33 million Calculation and evidence 400084000 − 115751000 USD Exact free cash flow: 284333000 USD 2018-01-01 – 2018-12-31: 400084000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 115751000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEXX LABORATORIES INC /DE · 2018-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Free cash flow: 284333000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 400084000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471621000008/idxx-20201231.htm#1807960 Filing: 000087471621000008 Input fundies:CapitalExpenditure: 115751000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471621000008/idxx-20201231.htm#1811915 Filing: 000087471621000008 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	USD 427.72 million Exact value Exact value: 427720000 USD 2019-01-01 – 2019-12-31: 427720000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDEXX LABORATORIES INC /DE · 2019-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Net Income: 427720000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 427720000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471622000007/idxx-20211231.htm#3015376 Filing: 000087471622000007 The citation records this snapshot. The page link may show a newer release later.	USD 459.16 million Exact value Exact value: 459158000 USD 2019-01-01 – 2019-12-31: 459158000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEXX LABORATORIES INC /DE · 2019-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Operating Cash Flow: 459158000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 459158000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471622000007/idxx-20211231.htm#1729833 Filing: 000087471622000007 The citation records this snapshot. The page link may show a newer release later.	USD 154.97 million Exact value Exact value: 154969000 USD 2019-01-01 – 2019-12-31: 154969000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEXX LABORATORIES INC /DE · 2019-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Capital Expenditure: 154969000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 154969000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471622000007/idxx-20211231.htm#1733794 Filing: 000087471622000007 The citation records this snapshot. The page link may show a newer release later.	USD 304.19 million Calculation and evidence 459158000 − 154969000 USD Exact free cash flow: 304189000 USD 2019-01-01 – 2019-12-31: 459158000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 154969000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEXX LABORATORIES INC /DE · 2019-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Free cash flow: 304189000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 459158000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471622000007/idxx-20211231.htm#1729833 Filing: 000087471622000007 Input fundies:CapitalExpenditure: 154969000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471622000007/idxx-20211231.htm#1733794 Filing: 000087471622000007 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 581.78 million Exact value Exact value: 581776000 USD 2020-01-01 – 2020-12-31: 581776000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDEXX LABORATORIES INC /DE · 2020-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Net Income: 581776000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 581776000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471623000006/idxx-20221231.htm#3028049 Filing: 000087471623000006 The citation records this snapshot. The page link may show a newer release later.	USD 648.06 million Exact value Exact value: 648063000 USD 2020-01-01 – 2020-12-31: 648063000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEXX LABORATORIES INC /DE · 2020-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Operating Cash Flow: 648063000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 648063000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471623000006/idxx-20221231.htm#1736771 Filing: 000087471623000006 The citation records this snapshot. The page link may show a newer release later.	USD 106.96 million Exact value Exact value: 106958000 USD 2020-01-01 – 2020-12-31: 106958000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEXX LABORATORIES INC /DE · 2020-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Capital Expenditure: 106958000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 106958000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471623000006/idxx-20221231.htm#1740747 Filing: 000087471623000006 The citation records this snapshot. The page link may show a newer release later.	USD 541.11 million Calculation and evidence 648063000 − 106958000 USD Exact free cash flow: 541105000 USD 2020-01-01 – 2020-12-31: 648063000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 106958000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEXX LABORATORIES INC /DE · 2020-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Free cash flow: 541105000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 648063000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471623000006/idxx-20221231.htm#1736771 Filing: 000087471623000006 Input fundies:CapitalExpenditure: 106958000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471623000006/idxx-20221231.htm#1740747 Filing: 000087471623000006 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 744.85 million Exact value Exact value: 744845000 USD 2021-01-01 – 2021-12-31: 744845000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDEXX LABORATORIES INC /DE · 2021-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Net Income: 744845000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 744845000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471624000057/idxx-20231231.htm#2504298 Filing: 000087471624000057 The citation records this snapshot. The page link may show a newer release later.	USD 755.55 million Exact value Exact value: 755546000 USD 2021-01-01 – 2021-12-31: 755546000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEXX LABORATORIES INC /DE · 2021-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Operating Cash Flow: 755546000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 755546000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471624000057/idxx-20231231.htm#1589615 Filing: 000087471624000057 The citation records this snapshot. The page link may show a newer release later.	USD 119.55 million Exact value Exact value: 119549000 USD 2021-01-01 – 2021-12-31: 119549000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEXX LABORATORIES INC /DE · 2021-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Capital Expenditure: 119549000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 119549000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471624000057/idxx-20231231.htm#1592387 Filing: 000087471624000057 The citation records this snapshot. The page link may show a newer release later.	USD 636 million Calculation and evidence 755546000 − 119549000 USD Exact free cash flow: 635997000 USD 2021-01-01 – 2021-12-31: 755546000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 119549000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEXX LABORATORIES INC /DE · 2021-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Free cash flow: 635997000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 755546000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471624000057/idxx-20231231.htm#1589615 Filing: 000087471624000057 Input fundies:CapitalExpenditure: 119549000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471624000057/idxx-20231231.htm#1592387 Filing: 000087471624000057 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 679.09 million Exact value Exact value: 679089000 USD 2022-01-01 – 2022-12-31: 679089000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDEXX LABORATORIES INC /DE · 2022-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Net Income: 679089000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 679089000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471625000037/idxx-20241231.htm#1529167 Filing: 000087471625000037 The citation records this snapshot. The page link may show a newer release later.	USD 542.98 million Exact value Exact value: 542984000 USD 2022-01-01 – 2022-12-31: 542984000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEXX LABORATORIES INC /DE · 2022-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Operating Cash Flow: 542984000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 542984000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471625000037/idxx-20241231.htm#1555234 Filing: 000087471625000037 The citation records this snapshot. The page link may show a newer release later.	USD 148.84 million Exact value Exact value: 148838000 USD 2022-01-01 – 2022-12-31: 148838000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEXX LABORATORIES INC /DE · 2022-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Capital Expenditure: 148838000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 148838000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471625000037/idxx-20241231.htm#1558006 Filing: 000087471625000037 The citation records this snapshot. The page link may show a newer release later.	USD 394.15 million Calculation and evidence 542984000 − 148838000 USD Exact free cash flow: 394146000 USD 2022-01-01 – 2022-12-31: 542984000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 148838000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEXX LABORATORIES INC /DE · 2022-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Free cash flow: 394146000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 542984000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471625000037/idxx-20241231.htm#1555234 Filing: 000087471625000037 Input fundies:CapitalExpenditure: 148838000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471625000037/idxx-20241231.htm#1558006 Filing: 000087471625000037 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	USD 845.04 million Exact value Exact value: 845042000 USD 2023-01-01 – 2023-12-31: 845042000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDEXX LABORATORIES INC /DE · 2023-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Net Income: 845042000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: 845042000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1464078 Filing: 000087471626000038 The citation records this snapshot. The page link may show a newer release later.	USD 906.51 million Exact value Exact value: 906510000 USD 2023-01-01 – 2023-12-31: 906510000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEXX LABORATORIES INC /DE · 2023-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Operating Cash Flow: 906510000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 906510000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1487907 Filing: 000087471626000038 The citation records this snapshot. The page link may show a newer release later.	USD 133.63 million Exact value Exact value: 133631000 USD 2023-01-01 – 2023-12-31: 133631000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEXX LABORATORIES INC /DE · 2023-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Capital Expenditure: 133631000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 133631000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1490732 Filing: 000087471626000038 The citation records this snapshot. The page link may show a newer release later.	USD 772.88 million Calculation and evidence 906510000 − 133631000 USD Exact free cash flow: 772879000 USD 2023-01-01 – 2023-12-31: 906510000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 133631000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEXX LABORATORIES INC /DE · 2023-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Free cash flow: 772879000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 906510000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1487907 Filing: 000087471626000038 Input fundies:CapitalExpenditure: 133631000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1490732 Filing: 000087471626000038 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	USD 887.87 million Exact value Exact value: 887867000 USD 2024-01-01 – 2024-12-31: 887867000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDEXX LABORATORIES INC /DE · 2024-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Net Income: 887867000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: 887867000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1463310 Filing: 000087471626000038 The citation records this snapshot. The page link may show a newer release later.	USD 929 million Exact value Exact value: 929001000 USD 2024-01-01 – 2024-12-31: 929001000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEXX LABORATORIES INC /DE · 2024-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Operating Cash Flow: 929001000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 929001000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1487253 Filing: 000087471626000038 The citation records this snapshot. The page link may show a newer release later.	USD 120.92 million Exact value Exact value: 120922000 USD 2024-01-01 – 2024-12-31: 120922000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEXX LABORATORIES INC /DE · 2024-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Capital Expenditure: 120922000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 120922000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1490140 Filing: 000087471626000038 The citation records this snapshot. The page link may show a newer release later.	USD 808.08 million Calculation and evidence 929001000 − 120922000 USD Exact free cash flow: 808079000 USD 2024-01-01 – 2024-12-31: 929001000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 120922000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEXX LABORATORIES INC /DE · 2024-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Free cash flow: 808079000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 929001000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1487253 Filing: 000087471626000038 Input fundies:CapitalExpenditure: 120922000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1490140 Filing: 000087471626000038 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	USD 1.06 billion Exact value Exact value: 1059464000 USD 2025-01-01 – 2025-12-31: 1059464000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDEXX LABORATORIES INC /DE · 2025-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Net Income: 1059464000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1059464000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1462541 Filing: 000087471626000038 The citation records this snapshot. The page link may show a newer release later.	USD 1.18 billion Exact value Exact value: 1181805000 USD 2025-01-01 – 2025-12-31: 1181805000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEXX LABORATORIES INC /DE · 2025-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Operating Cash Flow: 1181805000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1181805000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1486598 Filing: 000087471626000038 The citation records this snapshot. The page link may show a newer release later.	USD 124.68 million Exact value Exact value: 124676000 USD 2025-01-01 – 2025-12-31: 124676000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEXX LABORATORIES INC /DE · 2025-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Capital Expenditure: 124676000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 124676000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1489549 Filing: 000087471626000038 The citation records this snapshot. The page link may show a newer release later.	USD 1.06 billion Calculation and evidence 1181805000 − 124676000 USD Exact free cash flow: 1057129000 USD 2025-01-01 – 2025-12-31: 1181805000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 124676000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEXX LABORATORIES INC /DE · 2025-12-31 IDEXX LABORATORIES INC /DE (edgar:874716) Free cash flow: 1057129000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:55:28Z Snapshot: 89b4b7201ebc77cd059c4f0f4b417d251a0cac0448dac7401c7fbe51ddc81904 Dimensions: Consolidated View: https://fundies.io/companies/edgar/874716?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1181805000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1486598 Filing: 000087471626000038 Input fundies:CapitalExpenditure: 124676000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm#1489549 Filing: 000087471626000038 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

261 filings · 13,916 latest values · 13,916 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000874716, 874716, IDXX, edgar:874716, idxx

Also known as IDEXX LABORATORIES INC /DE

IDEXX LABORATORIES INC /DE

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation